187 related articles for article (PubMed ID: 19050262)
1. Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway.
Chen PH; Yang CR
J Immunol; 2008 Dec; 181(12):8441-9. PubMed ID: 19050262
[TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells.
Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J
Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment with denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC-3 cells.
Yang CR; Guh JH; Teng CM; Chen CC; Chen PH
Br J Pharmacol; 2009 Aug; 157(7):1175-85. PubMed ID: 19466993
[TBL] [Abstract][Full Text] [Related]
4. Comment on "Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway".
Wang W; Sun W; Zhang L
J Immunol; 2009 Aug; 183(4):2203; author reply 2203-4. PubMed ID: 19661264
[No Abstract] [Full Text] [Related]
5. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
[TBL] [Abstract][Full Text] [Related]
6. 'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells.
Toda M; Kawamoto T; Ueha T; Kishimoto K; Hara H; Fukase N; Onishi Y; Harada R; Minoda M; Kurosaka M; Akisue T
Int J Oncol; 2013 Sep; 43(3):703-12. PubMed ID: 23817777
[TBL] [Abstract][Full Text] [Related]
7. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.
Tsuji S; Hosotani R; Yonehara S; Masui T; Tulachan SS; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Ito D; Kami K; Mori T; Fujimoto K; Doi R; Imamura M
Int J Cancer; 2003 Aug; 106(1):17-25. PubMed ID: 12794752
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase/Akt positively regulates Fas (CD95)-mediated apoptosis in epidermal Cl41 cells.
Lu B; Wang L; Stehlik C; Medan D; Huang C; Hu S; Chen F; Shi X; Rojanasakul Y
J Immunol; 2006 Jun; 176(11):6785-93. PubMed ID: 16709838
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
Im J; Kim K; Hergert P; Nho RS
J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
[TBL] [Abstract][Full Text] [Related]
10. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL.
Li W; Zhang C; Chen C; Zhuang G
Cell Mol Immunol; 2007 Dec; 4(6):455-60. PubMed ID: 18163957
[TBL] [Abstract][Full Text] [Related]
11. The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma.
Weissinger D; Tagscherer KE; Macher-Göppinger S; Haferkamp A; Wagener N; Roth W
Mol Cancer; 2013 Oct; 12(1):120. PubMed ID: 24107265
[TBL] [Abstract][Full Text] [Related]
12. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B X protein upregulates decoy receptor 3 expression via the PI3K/NF-κB pathway.
Liang DY; Sha S; Yi Q; Shi J; Chen Y; Hou Y; Chang Q
Cell Signal; 2019 Oct; 62():109346. PubMed ID: 31229617
[TBL] [Abstract][Full Text] [Related]
14. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes.
Osawa Y; Banno Y; Nagaki M; Brenner DA; Naiki T; Nozawa Y; Nakashima S; Moriwaki H
J Immunol; 2001 Jul; 167(1):173-80. PubMed ID: 11418646
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y
Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580
[TBL] [Abstract][Full Text] [Related]
17. Expressions of Fas/DcR3 and RGD-FasL mediated apoptosis in pituitary adenomas.
Chen L; Tian X; Li W; Agarwal A; Zhuang G
Neurol India; 2009; 57(1):28-30. PubMed ID: 19305072
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH
Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665
[TBL] [Abstract][Full Text] [Related]
19. Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF-kappa B-dependent up-regulation of intercellular adhesion molecule-1, VCAM-1, and IL-8 expression.
Yang CR; Hsieh SL; Ho FM; Lin WW
J Immunol; 2005 Feb; 174(3):1647-56. PubMed ID: 15661928
[TBL] [Abstract][Full Text] [Related]
20. Decoy receptor 3 suppresses TLR2-mediated B cell activation by targeting NF-κB.
Huang ZM; Kang JK; Chen CY; Tseng TH; Chang CW; Chang YC; Tai SK; Hsieh SL; Leu CM
J Immunol; 2012 Jun; 188(12):5867-76. PubMed ID: 22581854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
